Contact us now for a free consultation with one of our HIFU experts!
Meet Dr. Ronald Wheeler in 2015 World Expert in Treating Prostate Cancer with High Intensity Focused Ultrasound (HIFU) while treating ►400 men Advantages: Out-patient procedure, No pain, Minimal side effects (Urethral narrowing ◄20%), Best outcome data in the world at 95% overall, “Sweet Spot Study” 98% Cure rate at 88 months when the PSA level … Continue reading “Meet Dr. Wheeler”Learn more
Purpose We describe the long-term cancer control and morbidity of high intensity focused ultrasound with neoadjuvant transurethral resection of the prostate, the risk of metastatic induction by transurethral prostate resection, and the evolution of high intensity focused ultrasound application and technology with time. Materials and Methods A prospective Harlaching high intensity focused ultrasound database was … Continue reading “HIFU Outcomes During 15 Years”Learn more
EDAP Receives FDA Approval for Ablatherm HIFU LYON, France, Nov. 9, 2015 (GLOBE NEWSWIRE) — EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Ablatherm® Integrated Imaging HIFU in the U.S. for the ablation of prostate tissue. EDAP … Continue reading “FDA Approval for Ablatherm HIFU”Learn more
Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use?
Curr Urol Rep. 2011 Jun;12(3):180-7. doi: 10.1007/s11934-011-0184-2. Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use? Chaussy CG1, Thüroff SF. Abstract High-intensity focused ultrasound (HIFU) is an emerging, noninvasive, local treatment of prostate cancer with 15 years of clinical experience, during which about 30,000 HIFU treatments have … Continue reading “Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use?”Learn more